Event Date: Sep 10, 2020

Recording | Related Resources

Depression is the most common mental illness in older adults. Social isolation and infection prevention measures to contain the COVID pandemic have disproportionately impacted older adults, putting them at even higher risk of depression. 

Telemedicine increases access to care in the setting of a pandemic and may improve clinical outcomes for society’s most vulnerable members. 

In a pandemic with physical distancing, older adults with depression lack access to or have a fear of seeking out (1) non-pharmacologic therapies and (2) health care providers.  Drs. Goodarzi, Watt and Holroyd-Leduc will cover the up to date evidence on how to treat depression remotely in older adults living in the community.





Zahra Goodarzi, BHSc (Hon). MD. MSc. FRCPC

Dr. Zahra Goodarzi is an academic geriatrician. She is currently an Assistant Professor in the Section of Geriatrics within the Department of Medicine at the University of Calgary. Her major research interests involve knowledge translation and qualitative methods to improve the lives of older adults. Specifically focused on the how to improve care for older adults with frailty, mental illness and neurologic diseases.


Jayna Holroyd-Leduc, BSc, MD, FRCPC

Dr. Jayna Holroyd-Leduc is an academic geriatrician. She completed residency training in Internal Medicine and Geriatrics at the University of Toronto, before completing a research fellowship in quality improvement and research methodology at the University of California, San Francisco through the VA Quality Scholar program. She is currently the Head of the Department of Medicine at the University of Calgary. Her major research interests involve the use of knowledge translation (KT) to improve the care provided to older adults. She is also the University of Calgary Brenda Strafford Foundation Chair in Geriatric Medicine.

Jennifer Watt, MD, PhD

Dr. Jennifer Watt (@JennAnnWatt) is an assistant professor in the Division of Geriatric Medicine, Department of Medicine at the University of Toronto. Her research focuses on the comparative efficacy and safety of pharmacologic and nonpharmacologic interventions in dementia. She received a 2019 CIHR Institutes of Health Services and Policy Research Rising Star Award for this work.